Mara Marongiu

Dr. Mara Marongiu

Institute for Genetic and Biomedical Research (IRGB), National Research Council (CNR), Lanusei (NU), Italy
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 September 2020 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
VOValeria Orrù
Valeria Orrù
MSMaristella Steri
Maristella Steri
CSCarlo Sidore
Carlo Sidore
MMMichele Marongiu
Michele Marongiu
VSValentina Serra
Valentina Serra
FCFrancesco Cucca
Francesco Cucca

21 November 2010 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CECathy E. Elks
Cathy E. Elks
JPJohn R.B. Perry
John R.B. Perry
PSPatrick Sulem
Patrick Sulem
DCDaniel I. Chasman
Daniel I. Chasman
NFNora Franceschini
Nora Franceschini
AMAnna Murray
Anna Murray

27 April 2017 in New England Journal of Medicine
Verified
Journal Article
Open access
PDF file
MSMaristella Steri
Maristella Steri
VOValeria Orrù
Valeria Orrù
MIM. Laura Idda
M. Laura Idda
MPMaristella Pitzalis
Maristella Pitzalis
MPMauro Pala
Mauro Pala
FCFrancesco Cucca
Francesco Cucca
Genomewide association studies of autoimmune diseases have mapped hundreds of susceptibility regions in the genome. However, only for a few association signals has the causal gene been identified, and for even fewer have the causal variant and underlying mechanism been defined. Coincident associations of DNA variants affecting both the risk of autoimmune disease and quantitative immune variables provide an informative route to explore disease mechanisms and drug-targetable pathways. Using case–control samples from Sardinia, Italy, we performed a genomewide association study in multiple sclerosis followed by TNFSF13B locus–specific association testing in systemic lupus erythematosus (SLE). Extensive phenotyping of quantitative immune variables, sequence-based fine mapping, cross-population and cross-phenotype analyses, and gene-expression studies were used to identify the causal variant and elucidate its mechanism of action. Signatures of positive selection were also investigated. A variant in TNFSF13B, encoding the cytokine and drug target B-cell activating factor (BAFF), was associated with multiple sclerosis as well as SLE. The disease-risk allele was also associated with up-regulated humoral immunity through increased levels of soluble BAFF, B lymphocytes, and immunoglobulins. The causal variant was identified: an insertion–deletion variant, GCTGT→A (in which A is the risk allele), yielded a shorter transcript that escaped microRNA inhibition and increased production of soluble BAFF, which in turn up-regulated humoral immunity. Population genetic signatures indicated that this autoimmunity variant has been evolutionarily advantageous, most likely by augmenting resistance to malaria. A TNFSF13B variant was associated with multiple sclerosis and SLE, and its effects were clarified at the population, cellular, and molecular levels. (Funded by the Italian Foundation for Multiple Sclerosis and others.)

22 January 2012 in Nature Genetics
Verified
Journal Article
Open access
PDF file
LSLisette Stolk
Lisette Stolk
JPJohn R B Perry
John R B Perry
DCDaniel I Chasman
Daniel I Chasman
CHChunyan He
Chunyan He
MMMassimo Mangino
Massimo Mangino
KLKathryn L Lunetta
Kathryn L Lunetta
Kathryn Lunetta and colleagues report a meta-analysis of 22 genome-wide association studies for age at menopause. They identify 13 loci newly associated with age at natural menopause, including several candidate genes with roles in DNA repair and immune function. To newly identify loci for age at natural menopause, we carried out a meta-analysis of 22 genome-wide association studies (GWAS) in 38,968 women of European descent, with replication in up to 14,435 women. In addition to four known loci, we identified 13 loci newly associated with age at natural menopause (at P < 5 × 10−8). Candidate genes located at these newly associated loci include genes implicated in DNA repair (EXO1, HELQ, UIMC1, FAM175A, FANCI, TLK1, POLG and PRIM1) and immune function (IL11, NLRP11 and PRRC2A (also known as BAT2)). Gene-set enrichment pathway analyses using the full GWAS data set identified exoDNase, NF-κB signaling and mitochondrial dysfunction as biological processes related to timing of menopause.

27 February 2013 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
DCDiana L. Cousminer
Diana L. Cousminer
DBDiane J. Berry
Diane J. Berry
NTNicholas J. Timpson
Nicholas J. Timpson
WAWei Ang
Wei Ang
ETElisabeth Thiering
Elisabeth Thiering
FCfor the Early Growth Genetics (EGG) Consortium
for the Early Growth Genetics (EGG) Consortium
The pubertal height growth spurt is a distinctive feature of childhood growth reflecting both the central onset of puberty and local growth factors. Although little is known about the underlying genetics, growth variability during puberty correlates with adult risks for hormone-dependent cancer and adverse cardiometabolic health. The only gene so far associated with pubertal height growth, LIN28B, pleiotropically influences childhood growth, puberty and cancer progression, pointing to shared underlying mechanisms. To discover genetic loci influencing pubertal height and growth and to place them in context of overall growth and maturation, we performed genome-wide association meta-analyses in 18 737 European samples utilizing longitudinally collected height measurements. We found significant associations (P < 1.67 × 10−8) at 10 loci, including LIN28B. Five loci associated with pubertal timing, all impacting multiple aspects of growth. In particular, a novel variant correlated with expression of MAPK3, and associated both with increased prepubertal growth and earlier menarche. Another variant near ADCY3-POMC associated with increased body mass index, reduced pubertal growth and earlier puberty. Whereas epidemiological correlations suggest that early puberty marks a pathway from rapid prepubertal growth to reduced final height and adult obesity, our study shows that individual loci associating with pubertal growth have variable longitudinal growth patterns that may differ from epidemiological observations. Overall, this study uncovers part of the complex genetic architecture linking pubertal height growth, the timing of puberty and childhood obesity and provides new information to pinpoint processes linking these traits.

6 May 2009 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SSSerena Sanna
Serena Sanna
FBFabio Busonero
Fabio Busonero
AMAndrea Maschio
Andrea Maschio
PMPatrick F. McArdle
Patrick F. McArdle
GUGianluca Usala
Gianluca Usala
Manuela UdaManuela Uda
Manuela Uda
Bilirubin, resulting largely from the turnover of hemoglobin, is found in the plasma in two main forms: unconjugated or conjugated with glucuronic acid. Unconjugated bilirubin is transported into hepatocytes. There, it is glucuronidated by UGT1A1 and secreted into the bile canaliculi. We report a genome wide association scan in 4300 Sardinian individuals for total serum bilirubin levels. In addition to the two known loci previously involved in the regulation of bilirubin levels, UGT1A1 (P = 6.2 × 10−62) and G6PD (P = 2.5 × 10−8), we observed a strong association on chromosome 12 within the SLCO1B3 gene (P = 3.9 × 10−9). Our findings were replicated in an independent sample of 1860 Sardinians and in 832 subjects from the Old Order Amish (combined P < 5 × 10−14). We also show that SLC01B3 variants contribute to idiopathic mild unconjugated hyperbilirubinemia. Thus, SLC01B3 appears to be involved in the regulation of serum bilirubin levels in healthy individuals and in some bilirubin-related disorders that are only partially explained by other known gene variants.